The effect of intravitreal triamcinolone on intraocular pressure

Current Medical Research and Opinion

Volumn 23, Issue 6, 2007, Pages 1253-1258

  Kramar, Mark ^a   Vu, Lani ^a   Whitson, Jess T ^a   He, Yu Guang ^a,b  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Glaucoma; Intraocular pressure; Intravitreal triamcinolone; Steroid response

Indexed keywords

BIMATOPROST; BRIMONIDINE; DORZOLAMIDE; DORZOLAMIDE PLUS TIMOLOL; LATANOPROST; TIMOLOL; TRAVOPROST; TRIAMCINOLONE ACETONIDE;

ADULT; AGED; ARTICLE; CLINICAL PRACTICE; DRUG EFFECT; FEMALE; FOLLOW UP; HUMAN; INTRAOCULAR PRESSURE; INTRAOCULAR PRESSURE ABNORMALITY; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; OPEN ANGLE GLAUCOMA; PATIENT SELECTION; RETINA DISEASE; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICAL ANALYSIS; STUDENT T TEST; TREATMENT DURATION;

ADULT; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS; DIABETIC RETINOPATHY; DRUG ADMINISTRATION ROUTES; DRUG ADMINISTRATION SCHEDULE; GLAUCOMA, OPEN-ANGLE; HUMANS; INJECTIONS; INTRAOCULAR PRESSURE; MACULAR DEGENERATION; MACULAR EDEMA; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; TRIAMCINOLONE;

EID: 34347223601     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079907X187946     Document Type: Article

References (23)

1. Gillies MC, Simpson JM, Billson FA, et al. Safety of an intravitreal injection of triamcinolone. Arch Ophthalmol 2004;122:336-40
2. Jonas JB, Kreissig I, Hugger P, et al. Intravitreal triamcinolone acetonide for exudative age related macular degeneration. Br J Ophthalmol 2003;87:462-8
3. Jonas JB, Sofker A. Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema. Am J Ophthalmol 2001;132:425-7
4. Greenberg PB, Martidis A, Rogers AH, et al. Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion. Br J Ophthalmol 2002;86:247-8
5. Jonas JB, Kreissig I, Sofker A, et al. Intravitreal injection of triamcinolone acetonide for diffuse macular edema. Arch Ophthalmol 2003;121:57-61
6. Martidis A, Duker JS, Greenberg PB, et al. Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology 2002;109:920-7
7. Antoszyk AN, Gottlieb JL, Machemer R, et al. The effects of intravitreal triamcinolone acetonide on experimental preretinal neovascularization. Graefes Arch Clin Exp Ophthalmol 1993;231:34-40
8. Gillies MC, Simpson JM, Luo W, et al. A randomized clinical trial of a single dose of intravitreal triamcinolone acetonide for neovascular age related macular degeneration. Arch Ophthalmol 2003;121:667-73
9. Penfold PL, Gyory JF, Hunyor AB, et al. Exudative macular degeneration and triamcinolone: a pilot study. Aust N Z J Ophthalmol 1995;23:293-8
10. Machemer R. Five cases in which a depot steroid (hydrocortisone acetate and methylprednisolone acetate) was injected into the eye. Retina 1996;16:166-7
11. McCluskey P, Forrester J, Lightman S. Uniocular macular oedema and reduced vision in a patient with uveitis. Clin Experiment Ophthalmol 2000;28:9-12
12. Wingate RJ, Beaumont PE. Intravitreal triamcinolone and elevated intraocular pressure. Aust N Z J Ophthalmol 1999;27:431-2
13. Young S, Larkin G, Branley M, et al. Safety and efficacy of intravitreal triamcinolone acetonide for cystoid macular oedema in uveitis. Clin Experiment Ophthalmol 2001;29:2-6
14. Martidis A, Duker JS, Puliafito CA. Intravitreal triamcinolone for refractory cystoid macular edema secondary to birdshot retinochoroidopathy. Arch Ophthalmol 2001;119:1380-3
15. Benhamou N, Massin P, Haouchine B, et al. Intravitreal triamcinolone for refractory pseudophakic macular edema. Am J Ophthalmol 2003;135:246-9
16. Becker B, Bresnick G, Chevrette L, et al. Intraocular pressure and its response to topical corticosteroids in diabetes. Arch Ophthalmol 1966;76:477-83
17. Becker B, Ballin N. Glaucoma and corticosteroid provocative testing. Arch Ophthalmol 1965;74:621-4
18. Bigger JF, Palmberg PF, Zink H, et al. Sensitivity to glucocorticoids in primary open angle glaucoma. N Engl J Med 1972;287:992
19. Bartlett JD, Woodley TW, Adams CM. Identification of high IOP responders to topical ophthalmic corticosteroids. J Ocular Pharmacol 1993;9:35-45
20. Bakri SJ, Beer PM. The effect of intravitreal triamcinolone acetonide on intraocular pressure. Ophthalmic Surg Lasers Imaging 2003;34:386-90
21. Jonas JB, Kreissig I, Degenring R. Intraocular pressure after intravitreal injection of triamcinolone acetonide. Br J Ophthalmol 2003;87:24-7
22. Beer PM, Sophie JB, Singh RJ, et al. Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection. Ophthalmology 2003;110:681-6
23. Lo WR, Rowlette LL, Caballero M, et al. Tissue differential microarray analysis of dexamethasone induction reveals potential mechanisms of steroid glaucoma. Invest Ophthalmol Vis Sci 2003;44:473-85